| Reference |
|---|
Uğurlu Çimen D, Odluyurt D, Sevinç K, Özkan Küçük N, Özçimen B, Demirtaş D, et al. AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation. Epigenetics Chromatin. 2021;14:32 pubmed publisher |
Güney Esken G, Erol Ö, Pervin B, Gürhan Sevinç G, Onder T, Bilgiç E, et al. Development, characterization, and hematopoietic differentiation of Griscelli syndrome type 2 induced pluripotent stem cells. Stem Cell Res Ther. 2021;12:287 pubmed publisher |
Nakanishi M, Mitchell R, Benoit Y, Orlando L, Reid J, Shimada K, et al. Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells. Cell. 2019;177:910-924.e22 pubmed publisher |
Whitworth D, Limnios I, Gauthier M, Weeratunga P, Ovchinnikov D, Baillie G, et al. Platypus Induced Pluripotent Stem Cells: the Unique Pluripotency Signature of a Monotreme. Stem Cells Dev. 2018;: pubmed publisher |
Rodriguez Gutierrez D, Eid W, Biason Lauber A. A Human Gonadal Cell Model From Induced Pluripotent Stem Cells. Front Genet. 2018;9:498 pubmed publisher |
Lee J, Salci K, Reid J, Orlando L, Tanasijevic B, Shapovalova Z, et al. Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations. Stem Cells. 2017;35:2095-2102 pubmed publisher |
Nayler S, Kozlov S, Lavin M, Wolvetang E. Lentiviral Reprogramming of A-T Patient Fibroblasts to Induced Pluripotent Stem Cells. Methods Mol Biol. 2017;1599:401-418 pubmed publisher |
Cheow L, Courtois E, Tan Y, Viswanathan R, Xing Q, Tan R, et al. Single-cell multimodal profiling reveals cellular epigenetic heterogeneity. Nat Methods. 2016;13:833-6 pubmed publisher |
Kim S, Oceguera Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, et al. KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Stem Cell Reports. 2015;4:727-43 pubmed publisher |
Whitworth D, Ovchinnikov D, Sun J, Fortuna P, Wolvetang E. Generation and characterization of leukemia inhibitory factor-dependent equine induced pluripotent stem cells from adult dermal fibroblasts. Stem Cells Dev. 2014;23:1515-23 pubmed publisher |
Onder T, Kara N, Cherry A, Sinha A, Zhu N, Bernt K, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012;483:598-602 pubmed publisher |
Nethercott H, Brick D, Schwartz P. Derivation of induced pluripotent stem cells by lentiviral transduction. Methods Mol Biol. 2011;767:67-85 pubmed publisher |
Yu J, Hu K, Smuga Otto K, Tian S, Stewart R, Slukvin I, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324:797-801 pubmed publisher |
